Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 11, 2010, Pages 4556-4560

  Mammeri, Hedi ^a   Guillon, Hélène ^a   Eb, François ^a   Nordmann, Patrice ^b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE ACT 1; BETA LACTAMASE AMPC; BETA LACTAMASE CMY 2; BETA LACTAMASE DHA 1; CARBAPENEM; CARBAPENEMASE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORINASE; HYDROLASE; IMIPENEM; OUTER MEMBRANE PROTEIN C; OUTER MEMBRANE PROTEIN F; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CHROMOSOME; BACTERIUM ISOLATION; BINDING SITE; BIOCHEMICAL COMPOSITION; CATALYSIS; CLONE; CONTROLLED STUDY; DRUG HYDROLYSIS; DRUG SENSITIVITY; ESCHERICHIA COLI; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; WILD TYPE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORINASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; IMIPENEM; KINETICS; MICROBIAL SENSITIVITY TESTS; PLASMIDS;

EID: 78049319835     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01762-09     Document Type: Article

References (33)

1. Bauvois, C., A. S. Ibuka, A. Celso, J. Alba, Y. Ishii, J. M. Frère, and M. Galleni. 2005. Kinetic properties of four plasmid-mediated AmpC β-lactamases. Antimicrob. Agents Chemother. 49:4240-4246.
2. Beadle, B. M., and B. K. Shoichet. 2002. Structural basis for imipenem inhibition of class C β-lactamases. Antimicrob. Agents Chemother. 46:3978-3980.
3. Bellais, S., D. Aubert, T. Naas, and P. Nordmann. 2000. Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing β-lactamases in Chryseobacterium meningosepticum. Antimicrob. Agents Chemother. 44: 1878-1886.
4. Bradford, P. A., C. Urban, N. Mariano, S. J. Projan, J. J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563-569.
5. Cao, V. T., G. Arlet, B. M. Ericsson, A. Tammelin, P. Courvalin, and T. Lambert. 2000. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J. Antimicrob. Chemother. 46:895-900.
6. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial. Susceptibility testing: 20th informational supplement. M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial. Susceptibility testing: 20th informational supplement (June 2010 Update). M100-S20-U. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Cornish-Bowden, A. 1995. Fundamentals of enzyme kinetics, p. 30-37. Port-land Press, Seattle, WA.
9. Fosse, T., C. Giraud-Morin, I. Madinier, and R. Labia. 2003. Sequence analysis and biochemical characterization of chromosomal CAV-1 (Aeromonas caviae), the parental cephalosporinase of plasmid-mediated AmpC 'FOX' cluster. FEMS Microbiol. Lett. 222:93-98.
10. Gonzalez Leiza, M., J. C. Perez-Diaz, J. Ayala, J. M. Casellas, J. Martinez-Beltran, K. Bush, and F. Baquero. 1994. Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated β-lactamase with two molecular variants. Antimicrob. Agents Chemother. 38:2150-2157.
11. Guex, N., and M. C. Peitsch. 1997. SWISS-MODEL and the Swiss-Pdb-Viewer: an environment for comparative protein modeling. Electrophoresis 18:2714-2723.
12. Kim, J. Y., H. I. Jung, Y. J. An, J. H. Lee, S. J. Kim, S. H. Jeong, K. J. Lee, P. G. Suh, H. S. Lee, S. H. Lee, and S. S. Cha. 2006. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C β-lactamase. Mol. Microbiol. 60:907-916.
13. Lakaye, B., A. Dubus, S. Lepage, S. Groslambert, and J.-M. Frère. 1999. When drug inactivation renders the target irrelevant to antibiotic resistance: a case story with β-lactams. Mol. Microbiol. 31:89-101.
14. Laemmli, U. K., and M. Favre. 1973. Maturation of the head of bacteriophage T4. I. DNA packaging events. J. Mol. Biol. 80:575-599.
15. Lee, K., D. Yong, Y. S. Choi, J. H. Yum, J. M. Kim, N. Woodford, D. M. Livermore, and Y. Chong. 2007. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 β-lactamases co-mediated by porin loss. Int. J. Antimicrob. Agents 29:201-206.
16. Lobkovsky, E., P. C. Moews, H. Liu, H. Zhao, J. M. Frere, and J. R. Knox. 1993. Evolution of an enzyme activity: crystallographic structure at 2-Å resolution of cephalosporinase from the ampC gene of Enterobacter cloacae P99 and comparison with a class A penicillinase. Proc. Natl. Acad. Sci. U. S. A. 90:11257-11261.
17. Mammeri, H., F. Eb, A. Berkani, and P. Nordmann. 2008. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital. J. Antimicrob. Chemother. 61:498-503.
18. Mammeri, H., M. Galleni, and P. Normann. 2009. Role of the Ser-287-Asn replacement in the hydrolysis spectrum extension of AmpC β-lactamases in Escherichia coli. Antimicrob. Agents Chemother. 53:323-326.
19. Mammeri, H., P. Nordmann, A. Berkani, and F. Eb. 2008. Contribution of extended-spectrum AmpC (ESAC) β-lactamases to carbapenem resistance in Escherichia coli. FEMS Microbiol. Lett. 282:238-240.
20. Mammeri, H., L. Poirel, and P. Nordmann. 2007. Extension of the hydrolysis spectrum of AmpC β-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix. J. Antimicrob. Chemother. 60:490-494.
21. Oteo, J., A. Delgado-Iribarren, D. Vega, V. Bautista, M. C. Rodriguez, M. Velasco, J. M. Saavedra, M. Perez-Vazquez, S. Garcia-Cobos, L. Martinez-Martinez, and J. Campos. 2008. Emergence of imipenem resistance in clinical Escherichia coli during therapy. Int. J. Antimicrob. Agents 32:534-537.
22. Peitsch, M. C. 1995. Protein modeling by e-mail. Biotechnology 13:658-660.
23. Peitsch, M. C. 1996. ProMod and Swiss-Model: internet-based tools for automated comparative protein modelling. Biochem. Soc. Trans. 24:274-279.
24. Philippon, A., G. Arlet, and G. Jacoby. 2002. Plasmid-determined AmpCtype β-lactamases. Antimicrob. Agents Chemother. 46:1-11.
25. Poirel, L., M. Guibert, D. Girlich, T. Naas, and P. Nordmann. 1999. Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morgannii clinical isolates. Antimicrob. Agents Chemother. 43:769-776.
26. Poirel, L., C. Héritier, C. Spicq, and P. Nordmann. 2004. In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J. Clin. Microbiol. 42:3831-3833.
27. Powers, R. A., E. Caselli, P. J. Focia, F. Prati, and B. K. Shoichet. 2001. Structures of ceftazidime and its transition-state analogue in complexe with AmpC β-lactamase: implications for resistance mutations and inhibitor design. Biochemistry 40:9207-9214.
28. Powers, R. A., and B. K. Shoichet. 2002. Structure based approach for binding site identification on AmpC β-lactamase. J. Med. Chem. 45:3222-3234.
29. MIR-1. Antimicrob. Agents Chemother. 48:4177-4182.
30. Rottman, M., Y. Benzerara, B. Hanau-Berçot, C. Bizet, A. Philippon, and G. Arlet. 2002. Chromosomal ampC genes in Enterobacter species other than Enterobacter cloacae, and ancestral association of the ACT-1 plasmid-encoded cephalosporinase to Enterobacter asburiae. FEMS Microbiol. Lett. 210:87-92.
31. Shimizu-Ibuka, A., C. Bauvois, H. Sakai, and M. Galleni. 2008. Structure of the plasmid-mediated class C β-lactamase ACT-1. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 64:334-337.
32. Stapleton, P. D., K. P. Shannon, and G. L. French. 1999. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 β-lactamase production and loss of an outer membrane protein. Antimicrob. Agents Chemother. 43:1206-1210.
33. Verdet, C., G. Arlet, S. Ben Redjeb, A. Ben Hassen, P. H. Lagrange, and A. Philippon. 1998. Characterisation of CMY-4, an AmpC-type plasmid-mediated β-lactamase in a Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol. Lett. 169:235-240.